A national survey on the management of psoriatic arthritis using the Delphi method
OBJECTIVES: Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists.
METHODS: A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66% of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66% of the respondents scoring an item 1 or 2.
RESULTS: The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis.
CONCLUSIONS: The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Clinical and experimental rheumatology - 35(2017), 2 vom: 08. März, Seite 214-220 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lubrano, Ennio [VerfasserIn] |
---|
Themen: |
Biological Products |
---|
Anmerkungen: |
Date Completed 13.06.2017 Date Revised 13.06.2017 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM264159780 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM264159780 | ||
003 | DE-627 | ||
005 | 20231224205457.0 | ||
007 | tu | ||
008 | 231224s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0880.xml |
035 | |a (DE-627)NLM264159780 | ||
035 | |a (NLM)27607572 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lubrano, Ennio |e verfasserin |4 aut | |
245 | 1 | 2 | |a A national survey on the management of psoriatic arthritis using the Delphi method |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 13.06.2017 | ||
500 | |a Date Revised 13.06.2017 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists | ||
520 | |a METHODS: A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66% of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66% of the respondents scoring an item 1 or 2 | ||
520 | |a RESULTS: The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis | ||
520 | |a CONCLUSIONS: The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Biological Products |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
700 | 1 | |a Cantini, Fabrizio |e verfasserin |4 aut | |
700 | 1 | |a Mathieu, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Olivieri, Ignazio |e verfasserin |4 aut | |
700 | 1 | |a Salvarani, Carlo |e verfasserin |4 aut | |
700 | 1 | |a Scarpa, Raffaele |e verfasserin |4 aut | |
700 | 1 | |a Marchesoni, Antonio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and experimental rheumatology |d 1989 |g 35(2017), 2 vom: 08. März, Seite 214-220 |w (DE-627)NLM012613010 |x 0392-856X |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2017 |g number:2 |g day:08 |g month:03 |g pages:214-220 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2017 |e 2 |b 08 |c 03 |h 214-220 |